Genmab
GMAB
$31.64
Share price
-0.69%
Change (1 day)
-28.11%
Change (1 year)
Categories
Earnings for Genmab (GMAB)
Earnings in 2024 (TTM): A$2.01 Billion
According to Genmab's latest financial reports the company's current earnings are A$3.10 Billion. , an increase over its 2023 earnings that were of A$1.25 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genmab from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | A$2.06 B | 63.99% |
| 2023 | A$1.25 B | -17.29% |
| 2022 | A$1.52 B | 55.87% |
| 2021 | A$0.97 B | -31.09% |
| 2020 | A$1.41 B | 111.51% |
| 2019 | A$0.67 B | 69.44% |
| 2018 | A$0.39 B | 49.63% |
| 2017 | A$0.26 B | 3.27% |
| 2016 | A$0.25 B | 46.33% |
| 2015 | A$0.17 B | 117.13% |
| 2014 | A$80.6 M | 329.17% |
| 2013 | A$18.78 M | -159.26% |
| 2012 | -A$31.7 Million | -48.96% |
| 2011 | -A$62.1 Million | 90.86% |
| 2010 | -A$32.54 Million | -67.46% |
| 2009 | -A$100 Million |